In vitro activities of panduratin A against clinical Staphylococcus strains

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4529-4532

  Rukayadi, Yaya ^a,b   Lee, Kwanghyung ^a   Han, Sunghwa ^a   Yong, Dongeun ^a   Hwang, Jae Kwan ^a  

^a Yonsei University   (South Korea)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CHALCONE DERIVATIVE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PANDURATIN A; TETRACYCLINE; THYMOL; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG SENSITIVITY; DRUG STRUCTURE; IN VITRO STUDY; METHICILLIN RESISTANT COAGULASE NEGATIVE STAPHYLOCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE COAGULASE NEGATIVE STAPHYLOCOCCUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; CHALCONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STAPHYLOCOCCUS; ZINGIBERACEAE;

EID: 70349315436     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00624-09     Document Type: Article

References (18)

1. Archer, G. L., and M. W. Climo. 2005. Staphylococcus epidermidis and other coagulase negative staphylococci, p. 2352-2362. In G. L. Mandel, J. E. Bennet, and R. Dolin (ed.), Principles and practice of infection disease. Elsevier Churchill Livingston, Philadelphia, PA.
2. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 384-404. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
3. Clinical and Laboratory Standards Institute. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. CLSI, Wayne, PA.
4. Emori, T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442.
5. French, G. L. 2006. Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin. J. Antimicrob. Chemother. 58: 1107-1117.
6. Hwang, J. K., J. S. Shim, and J. Y. Chung. 2004. Anticariogenic activity of some tropical medicinal plants against Streptococcus mutans. Fitoterapia 75:596-598.
7. Liao, M., P. S. Ruddock, A. S. Rizvi, S. H. Hall, F. S. French, and J. R. Dillon. 2005. Catinic peptide of the male reproductive tract, HE2α, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. J. Antimicrob. Chemother. 56:957-961. (Pubitemid 41631927)
8. Lowy, F. D. 1998. Medical progress: Staphylococcus aureus infections. N. Engl. J. Med. 339:520-530.
9. Machado, T. B., A. V. Pinto, M. C. F. R. Pinto, I. C. R. Leal, M. G. Silva, A. C. F Amaral, R. M. Kuster, and K. R. Netto-dosSantos. 2003. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int. J. Antimicrobiol. Agents 21:279-284.
10. Nishizawa, K., M. Hirano, A. Kimura, T. Mochizuki, Y. Yamamoto, S. Yamamura, and Y. Momose. 1998. Evaluation of the antimicrobial activity of carbapenem and cephem antibiotics against Pseudomonas aeruginosa isolated from hospitalized patients. J. Infect. Chemother. 4:174-176.
11. Nostro, A., A. S. Roccaro, G. Bisignano, A. Marino, M. A. Cannatelli, F. G. Pizzimenti, P. L. Cioni, F. Procopio, and A. R. Blanco. 2007. Effect of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol. 56:519-523.
12. Otsuka, N., M.-H. Liu, S. Shiota, W. Ogawa, T. Kuroda, T. Hatano, and T. Tsuchiya. 2008. Anti-methicillin resistant Staphylococcus aureus (MRSA) compounds isolated from Laurus nobilis. Biol. Pharm. Bull. 31:1794-1797.
13. Park, K. M., J. H. Choo, J. H. Sohn, S. H. Lee, and J. K. Hwang. 2005. Antibacterial activity of panduratin A isolated from Kaempferia pandurata against Porphyromonas gingivalis. Food Sci. Biotechnol. 14:286-289.
14. Rupp, M. E., and G. L. Archer. 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19:231-245.
15. Song, M. S., J. S. Shim, S. H. Gwon, C. W. Lee, H. S. Kim, and J. K. Hwang. 2008. Antibacterial activity of panduratin A and isopanduratin A isolated from Kaemfperia pandurata Roxb. against acne-causing microorganisms. Food Sci. Biotechnol. 17:1357-1360.
16. Yanti, Y. Rukayadi, K.-H. Lee, and J. K. Hwang. 2009. Activity of panduratin A isolated from Kaempferia pandurata Roxb. against multi-species oral bio- films in vitro. J. Oral Sci. 51:87-95.
17. Yong, D., J. H. Yum, K. Lee, Y. Chong, S. H. Choi, and J. K. Rhee. 2004. In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 48:352-357.
18. Yum, J. L., C. K. Kim, D. Yong, K. Lee, Y. Chong, C. M. Kim, J. M. Kim, S. Ro, and J. M. Cho. 2007. In vitro activity of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea. Antimicrob. Agents Chemother. 51:2591-2593.